Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatoly Nemets

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Harefuah|June 18, 2011
[The new anticoagulants]Anatoly Nemets, Michael Lishner, Gilles Lugassy
Acta Haematologica|January 21, 2006
Chronic paraneoplastic cutaneous syndrome preceding an indolent variant of mantle cell lymphoma: favorable response to rituximabAnatoly Nemets, Meir Ronen, Gilles Lugassy
The American Journal of Medicine|September 24, 2004
Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entityGilles Lugassy, Rachel Shaham, Anatoly Nemets, et al.
The Israel Medical Association Journal : IMAJ|January 12, 2007
Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomyAnatoly Nemets, Irina Isakov, Michael Huerta, et al.
Acta Haematologica|December 4, 2024
"Real-Life" Data of Zanubrutinib in Patients with Waldenström Macroglobulinemia: A Multicenter Retrospective StudyGilad Itchaki, Ohad Benjamini, Mor Levi, et al.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Clinical Medicine|September 28, 2023
MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin LevelYael Haring, Noa Goldschmidt, Shaimaa Taha, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndromeYishai Ofran, Kalman Filanovsky, Anat Gafter-Gvili, et al.
American Journal of Hematology|January 25, 2013
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter studyDrorit Merkel, Kalman Filanovsky, Anat Gafter-Gvili, et al.
Leukemia & Lymphoma|September 28, 2020
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experienceYafit Segman, Elena Ribakovsky, Abraham Avigdor, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Harefuah|June 18, 2011
[The new anticoagulants]Anatoly Nemets, Michael Lishner, Gilles Lugassy
Acta Haematologica|January 21, 2006
Chronic paraneoplastic cutaneous syndrome preceding an indolent variant of mantle cell lymphoma: favorable response to rituximabAnatoly Nemets, Meir Ronen, Gilles Lugassy
The American Journal of Medicine|September 24, 2004
Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entityGilles Lugassy, Rachel Shaham, Anatoly Nemets, et al.
The Israel Medical Association Journal : IMAJ|January 12, 2007
Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomyAnatoly Nemets, Irina Isakov, Michael Huerta, et al.
Acta Haematologica|December 4, 2024
"Real-Life" Data of Zanubrutinib in Patients with Waldenström Macroglobulinemia: A Multicenter Retrospective StudyGilad Itchaki, Ohad Benjamini, Mor Levi, et al.
Blood|April 7, 2010
Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group reportSigal Grisariu, Batia Avni, Tracy T Batchelor, et al.
Journal of Clinical Medicine|September 28, 2023
MDS-Related Anemia Is Associated with Impaired Quality of Life but Improvement Is Not Always Achieved by Increased Hemoglobin LevelYael Haring, Noa Goldschmidt, Shaimaa Taha, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndromeYishai Ofran, Kalman Filanovsky, Anat Gafter-Gvili, et al.
American Journal of Hematology|January 25, 2013
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter studyDrorit Merkel, Kalman Filanovsky, Anat Gafter-Gvili, et al.
Leukemia & Lymphoma|September 28, 2020
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experienceYafit Segman, Elena Ribakovsky, Abraham Avigdor, et al.
Pageof 2